July 09, 2026
Market insights predict the global biologics CDMO industry will increase from USD 29.34 billion in 2026 to USD 107.17 billion by 2035, achieving a CAGR of 15.48%. In 2024, North America led the biologics CDMO market with 37% share. Asia-Pacific is ex...
July 08, 2026
According to Rohan Patil, who specializes in biopharmaceuticals, biotechnology, and healthcare market research, with 5+ years of experience in market research and industry analysis, this research indicates that the biologics market is set to grow fro...
June 24, 2026
According to Shivani Zoting, who specializes in biopharmaceuticals, healthcare research, and life sciences market analysis, with 5+ years of experience in market research and industry analysis. Her research reveals that the biologics contract manufac...
July 23, 2026
According to Payal Rabde, who specializes in biologics, comprehensive health services, and healthcare market intelligence, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunitie...
April 21, 2026
According to market projections, the biologics contract research organization sector is expected to grow from USD 31.15 billion in 2024 to USD 106.28 billion by 2034, reflecting a CAGR of 13.04%.The market is growing due to the rising demand for biol...
July 16, 2026
Market insights predict, the biologics safety testing industry is expected to grow from USD 5.20 billion in 2026 to USD 16.45 billion by 2035, driven by a CAGR of 13.64%. The growing demand for biologics and growing research and development activitie...
April 21, 2026
Projections indicate that, the global Latin America life science market will increase from USD 4.49 billion in 2024 to USD 12.05 billion by 2034, experiencing a CAGR of 10.38% over the next 10 years. The market is expanding rapidly due to rising R&am...
August 03, 2026
Inhalable Biologics Market (By Type: Peptides and Proteins, Vaccines, Monoclonal Antibodies, RNAi-based Therapeutics, Others; By Application: Respiratory diseases, COPD, Asthma, Cystic Fibrosis, COVID-19, Others, Diabetes, Cancer, Others; By Dosage F...
April 21, 2026
Market insights predict, the osteoarthritis therapeutics industry is expected to grow from USD 9.95 billion in 2024 to USD 24.52 billion by 2034, driven by a CAGR of 9.45%. The rising prevalence of osteoarthritis is estimated to drive the growth of t...
February 17, 2026
According to our market projections, the global filtration in biologics market, valued at USD 8.44 billion in 2025, is anticipated to reach USD 29.01 billion by 2035, growing at a CAGR of 13.14% over the next decade. North America was dominant w...
February 17, 2026
According to market projections, the subcutaneous biologics sector is expected to grow from USD 2.1 billion in 2025 to USD 6.01 billion by 2035, reflecting a CAGR of 11.09%. The growing demand for self-administration and the need for targeted therapy...
July 07, 2026
Based on market forecasts, the spine biologics sector will expand from USD 4.89 billion in 2026 to USD 7.72 billion by 2035, experiencing a CAGR of 5.20%. Key drivers of the market's expansion include the rising incidence of degenerative spine illnes...
April 21, 2026
According to market projections, the global cancer biologics market, valued at USD 110.91 billion in 2024, is anticipated to reach USD 232.02 billion by 2034, growing at a CAGR of 7.66% over the next decade. Rising cancer research is anticipated...
April 21, 2026
According to market projections, the global retinal biologics market, valued at USD 29.14 billion in 2026, is anticipated to reach USD 57.86 billion by 2035, growing at a CAGR of 7.92% over the next decade. The growing geriatric population drives the...
April 21, 2026
Market insights predict, the myasthenia gravis industry is expected to grow from USD 1.45 billion in 2024 to USD 2.95 billion by 2034, driven by a CAGR of 7.35%. In 2024, North America led the myasthenia gravis market, with Asia Pacific set for the f...
April 21, 2026
According to market projections, the cell culture sector is expected to grow from USD 20.61 billion in 2024 to USD 60.38 billion by 2034, reflecting a CAGR of 11.35%. The increasing incidences of chronic disorders, growing research and development,...
April 21, 2026
The next-generation therapy market is expanding due to increasing use of cell and gene therapies as well as rising developments in RNA-based therapies. North America led the market due to the robust industries....
April 21, 2026
According to forecasts, the global pharmaceutical drying equipment market will grow from USD 5.84 billion in 2024 to USD 11.64 billion by 2034, with an expected CAGR of 7.14%. Rising demand for biologics and vaccines is estimated to drive the growt...
April 21, 2026
The life science CDMO market is expanding due to it offers inclusive services from drug development through drug manufacturing, and it majorly focuses on affordability and sustainability by reducing the environmental impact, patient-centric approache...
March 13, 2026
Market insights predict, the orthopedic devices industry is expected to grow from USD 65.8 billion in 2025 to USD 100.63 billion by 2035, driven by a CAGR of 4.34%. The rising prevalence of orthopedic disorders and advancements in medical devices are...